Minerva Neurosciences Inc (NERV)
2.37
+0.02
(+0.85%)
USD |
NASDAQ |
May 03, 16:00
2.41
+0.04
(+1.69%)
After-Hours: 20:00
Minerva Neurosciences Cash and Short Term Investments (Quarterly): 40.91M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 40.91M |
| September 30, 2023 | 46.90M |
| June 30, 2023 | 51.80M |
| March 31, 2023 | 35.98M |
| December 31, 2022 | 36.09M |
| September 30, 2022 | 40.22M |
| June 30, 2022 | 49.75M |
| March 31, 2022 | 54.95M |
| December 31, 2021 | 60.76M |
| September 30, 2021 | 65.59M |
| June 30, 2021 | 74.21M |
| March 31, 2021 | 80.14M |
| December 31, 2020 | 25.36M |
| September 30, 2020 | 32.52M |
| June 30, 2020 | 35.25M |
| March 31, 2020 | 37.51M |
| December 31, 2019 | 45.85M |
| September 30, 2019 | 59.93M |
| June 30, 2019 | 69.29M |
| March 31, 2019 | 79.16M |
| December 31, 2018 | 88.00M |
| Date | Value |
|---|---|
| September 30, 2018 | 97.61M |
| June 30, 2018 | 108.49M |
| March 31, 2018 | 121.00M |
| December 31, 2017 | 128.16M |
| September 30, 2017 | 132.93M |
| June 30, 2017 | 77.57M |
| March 31, 2017 | 85.36M |
| December 31, 2016 | 82.98M |
| September 30, 2016 | 91.85M |
| June 30, 2016 | 97.06M |
| March 31, 2016 | 44.64M |
| December 31, 2015 | 32.20M |
| September 30, 2015 | 37.49M |
| June 30, 2015 | 35.39M |
| March 31, 2015 | 52.20M |
| December 31, 2014 | 18.55M |
| September 30, 2014 | 23.64M |
| June 30, 2014 | 0.48M |
| March 31, 2014 | 2.141M |
| December 31, 2013 | 1.818M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
25.36M
Minimum
Dec 2020
80.14M
Maximum
Mar 2021
49.63M
Average
46.90M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Viking Therapeutics Inc | 962.98M |
| Janux Therapeutics Inc | 344.03M |
| ACADIA Pharmaceuticals Inc | 438.86M |
| Karyopharm Therapeutics Inc | 191.44M |
| Calidi Biotherapeutics Inc | 1.949M |